Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - April 2014


Modern Approaches to Identifying, Understanding and Controlling Variables and Transfer of Knowledge

14 Apr 2014 - 14 Apr 2014 - BioCity Edinburgh, UK



Bookmark and Share


Validated processes can often fail during the transfer stage and result in non-value added investment of resources to troubleshoot the problems. Two main reasons for this are; either the variables which contribute to inconsistencies of the outcome of the procedure have not been identified or controlled adequately or the transfer of knowledge of the process has not been performed effectively.   Whatever the process may be identifying, understanding and controlling variables is a key strategy towards enabling the process to perform to give a consistent outcome during routine use. In the event the process has to be transferred to a new environment, effective knowledge transfer of the process is vital to success.   There are many courses available today which cover the quality by design approach to developing manufacturing processes and analytical procedures so why should you attend this workshop? A process is a process and this one day practical workshop provides the opportunity to learn and apply the basic skills required to investigate, identify and understand variables, to develop a consistent process and transfer the knowledge of that process successfully. Participants will have the opportunity to use quality by design tools and concepts such as the target profile, risk assessment and control strategy to develop a simple process through experimentation and data analysis and then communicate it effectively to others. The skill set and mindset experienced during the classroom team exercises will provide a solid foundation when dealing with industry processes This workshop was designed to provide hands on experience using QbD tools and concepts such as the target profile, risk assessment and control strategy by applying them in the design and development of a simple process. This is achieved through experimentation with a statapult and/or making “Tasty Tablets”. The actual classroom process(s) will depend on the number and the background of attendees.

Further information
Scientific News
Natural Protein Points to New Inflammation Treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
Crouching Protein, Hidden Enzyme
A new study led by scientists at The Scripps Research Institute (TSRI) and the University of California (UC), Berkeley shows how a crucial molecular enzyme starts in a tucked-in somersault position and flips out when it encounters the right target.
Utilizing Antibodies from Ebola Survivors
A collaborative team from The University of Texas Medical Branch at Galveston, Vanderbilt University, The Scripps Research Institute and Integral Molecular Inc. have learned that antibodies in the blood of people who have survived a strain of the Ebola virus can kill various types of Ebola.
Engineering Foe into Friend
Bose Grant awardee Jacquin Niles aims to repurpose the malaria parasite for drug delivery.
Important Regulator of Immune System Decoded
Plasma cells play a key role in our immune system. Now scientists at the Research Institute of Molecular Pathology (IMP) in Vienna, Austria, and at the Walter and Eliza Hall Institute (WEHI) in Melbourne, Australia, succeeded in characterizing a central regulator of plasma cell function.
Bacterial Superglue for Faster Vaccine Development
An interdisciplinary team of Oxford University researchers has devised a new technique to speed up the development of novel vaccines.
Enumeral, MD Anderson Enter Into Collaboration
Strategic collaboration aims to discover and develop potentially novel antibodies against specified targets for immunotherapy.
Joint venture for GlycoMar Limited and MicroA AS
Scottish biotechnology company GlycoMar and Norwegian technology company MicroA are pleased to announce their joint venture business Prasinotech Ltd. The new company is registered in Scotland.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!